Investments
8Portfolio Exits
9Partners & Customers
10Service Providers
3About Roche
Roche (OTCQX: RHHBY) (OTCQX: RHHBF) operates as a multinational research-focused healthcare company. It discovers, develops, and provides diagnostic and therapeutic products and services. Roche operates worldwide under two divisions which are the pharmaceuticals division and the diagnostics division. The company was founded in 1896 and is based in Basel, Switzerland.
Want to inform investors similar to Roche about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Expert Collections containing Roche
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Roche in 6 Expert Collections, including Cancer.
Cancer
105 items
Products/services that analyze tumor-derived biomarkers (ctDNA, CTCs, exosomes) in blood/urine/other non-invasive liquid specimens to detect cancer earlier, guide treatment, and monitor progress. *Data fields manually updated as new information becomes available.'
Conference Exhibitors
5,302 items
Diabetes
1,904 items
Medical Devices
4,400 items
https://www.advamed.org/membership-join/membership-directory/ - excludes those without working websites.
Health Monitoring & Diagnostics
984 items
At-home IVD test developers, at-home sample collection device developers, at-home testing service providers, and all other companies playing in the at-home testing ecosystem. Companies tagged as #AtHomeTestingEcosystem
Biopharma Tech
260 items
Research containing Roche
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Roche in 5 CB Insights research briefs, most recently on Nov 15, 2022.
Latest Roche News
May 5, 2023
Roche Diabetes Care starts making blood glucose meters in India-Business Journal Share post: Roche Diabetes Care India has began manufacturing its blood glucose monitoring gadget ‘Accu-Chek Active’ in India. The firm has collaborated with Sanmina-SCI India and Parekh Integrated Services for manufacturing and distribution of the product, respectively. The manufacturing of Accu-Chek Active metres will happen in Sanmina’s multi-client manufacturing website in Chennai, in line with globally authorized high quality requirements, the corporate has mentioned. The new Accu-Chek Active product packs will now show the ‘Made in India’ tag, it added. The determination to fabricate these merchandise in India will scale back the time to market and assist RDC India contribute to the worldwide sustainability objectives of decreasing their carbon footprint versus imports. The first batch of Accu-Chek Active metres manufactured in India are already accessible in the market throughout the nation, Roche mentioned. Omar Sherief Mohammad, RDC – Cluster Head (India Middle East and Africa) mentioned, “This move is in line with our commitment to improve access to diabetes care by shortening our time to market and become more sustainable in our operations by reducing our carbon footprint.” Mike Landy, President and Chief Operating Officer of Integrated Manufacturing Services of Sanmina mentioned, “Sanmina has had a long-standing presence in India for over 20 years. Today Sanmina provides end-to-end services, including product design, advanced technologies, manufacturing, and logistics solutions from our 100-acre campus to companies that have mission critical applications and products, like Roche.” Vikram H Parekh, Chairman and Director, PISPL mentioned, they’d been related to the model for the previous twenty years, offering kitting, warehousing and distribution options for his or her Accu-Chek Active metres at Bhiwandi (Maharashtra). “Our warehouse at Bhiwandi is fully sustainable having received the Green Warehouse Interior Fit-out certification by the Indian Green Building Council (GBC) in November 2022.” SHARE
Roche Investments
8 Investments
Roche has made 8 investments. Their latest investment was in Lead Pharma as part of their Project Finance on November 11, 2020.
Roche Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
11/17/2020 | Project Finance | Lead Pharma | $11.86M | Yes | 1 | |
4/8/2020 | Project Finance | |||||
12/19/2019 | Partnership | |||||
10/28/2019 | Biz Plan Competition | |||||
10/2/2018 | Partnership |
Date | 11/17/2020 | 4/8/2020 | 12/19/2019 | 10/28/2019 | 10/2/2018 |
|---|---|---|---|---|---|
Round | Project Finance | Project Finance | Partnership | Biz Plan Competition | Partnership |
Company | Lead Pharma | ||||
Amount | $11.86M | ||||
New? | Yes | ||||
Co-Investors | |||||
Sources | 1 |
Roche Portfolio Exits
9 Portfolio Exits
Roche has 9 portfolio exits. Their latest portfolio exit was Ariosa Diagnostics on August 16, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
8/16/2021 | Acquired - II | 2 | |||
Date | 8/16/2021 | ||||
|---|---|---|---|---|---|
Exit | Acquired - II | ||||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 2 |
Roche Acquisitions
57 Acquisitions
Roche acquired 57 companies. Their latest acquisition was Good Therapeutics on September 07, 2022.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
9/7/2022 | Series B | $30.19M | Acquired | 14 | ||
9/9/2021 | Acquired | 1 | ||||
3/15/2021 | Acq - Pending | 26 | ||||
10/7/2020 | Series B | |||||
9/21/2020 | Grant |
Date | 9/7/2022 | 9/9/2021 | 3/15/2021 | 10/7/2020 | 9/21/2020 |
|---|---|---|---|---|---|
Investment Stage | Series B | Series B | Grant | ||
Companies | |||||
Valuation | |||||
Total Funding | $30.19M | ||||
Note | Acquired | Acquired | Acq - Pending | ||
Sources | 14 | 1 | 26 |
Roche Partners & Customers
10 Partners and customers
Roche has 10 strategic partners and customers. Roche recently partnered with PicnicHealth on April 4, 2023.
Date | Type | Business Partner | Country | News Snippet | Sources |
|---|---|---|---|---|---|
4/25/2023 | Vendor | United States | PicnicHealth, Roche partner to accelerate neurological disease research `` We 're delighted to continue our long-term partnership with Roche and Genentech as we leverage our expertise in working with patients to develop data while enabling researchers to better understand disease progression and staging and the holistic impact a neurological disease has on a patient and his of her care team , '' Dr. Dan Drozd , chief medical officer at PicnicHealth , said in a statement . | 1 | |
3/29/2023 | Partner | Belgium, and Hong Kong | `` Through this strategic partnership with DrGo , Roche and the Hong Kong Society for Rehabilitation , 100.000 people in Hong Kong will be able to monitor their heart health quickly and conveniently , improving the efficiency of their overall health management . '' | 1 | |
3/28/2023 | Licensee | Japan | `` We hope that we can deliver greater VALUE to patients by expanding our partnership with Welldoc , Inc. through BlueStar and connected insights with Roche Diabetes Care 's glucose meters . '' | 3 | |
3/27/2023 | Licensor | ||||
3/22/2023 | Licensee |
Date | 4/25/2023 | 3/29/2023 | 3/28/2023 | 3/27/2023 | 3/22/2023 |
|---|---|---|---|---|---|
Type | Vendor | Partner | Licensee | Licensor | Licensee |
Business Partner | |||||
Country | United States | Belgium, and Hong Kong | Japan | ||
News Snippet | PicnicHealth, Roche partner to accelerate neurological disease research `` We 're delighted to continue our long-term partnership with Roche and Genentech as we leverage our expertise in working with patients to develop data while enabling researchers to better understand disease progression and staging and the holistic impact a neurological disease has on a patient and his of her care team , '' Dr. Dan Drozd , chief medical officer at PicnicHealth , said in a statement . | `` Through this strategic partnership with DrGo , Roche and the Hong Kong Society for Rehabilitation , 100.000 people in Hong Kong will be able to monitor their heart health quickly and conveniently , improving the efficiency of their overall health management . '' | `` We hope that we can deliver greater VALUE to patients by expanding our partnership with Welldoc , Inc. through BlueStar and connected insights with Roche Diabetes Care 's glucose meters . '' | ||
Sources | 1 | 1 | 3 |
Roche Service Providers
3 Service Providers
Roche has 3 service provider relationships
Service Provider | Associated Rounds | Provider Type | Service Type |
|---|---|---|---|
Acq - Pending | Commercial Bank | Financial Advisor | |
Service Provider | |||
|---|---|---|---|
Associated Rounds | Acq - Pending | ||
Provider Type | Commercial Bank | ||
Service Type | Financial Advisor |
Partnership data by VentureSource
Roche Team
74 Team Members
Roche has 74 team members, including current Chief Executive Officer, President, German De La.
Name | Work History | Title | Status |
|---|---|---|---|
German De La | Chief Executive Officer, President | Current | |
Name | German De La | ||||
|---|---|---|---|---|---|
Work History | |||||
Title | Chief Executive Officer, President | ||||
Status | Current |
Compare Roche to Competitors
Aspira Women's Health is a health and biotechnology solutions company. The company develops and utilizes novel diagnostic and bio-analytical solutions that help physicians diagnose and treat gynecologic health for women. It is based in Austin, Texas.
MDCalc offers an online platform to help medical professionals do calculations, process algorithms, and scores, and assess risk using the evidence, all to make patients better and faster. It was founded in 2005 and is based in New York.
BRAVIS is a software and system house. It develops high-end internet-based video conference systems.
Insilico Medicine provides pharmaceutical and biotechnology companies with artificial intelligence solutions for research and development. It develops a range of generative adversarial networks (GANs) and reinforcement learning approaches to identify protein targets, generate molecular structures, and generate synthetic data. It was founded in 2014 and is based in Hong Kong, Hong Kong.
Genei offers digital research tools that aim to help users with productivity through custom AI algorithms. The company's platform summarizes articles and analyzes research.
FoodMarble has developed a personal digestive tracker. Based on validated clinical technology, this tiny breath test device and app can be used with the help of AI to help people work out what foods are most compatible with their unique digestive system.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.